Cargando…
Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
Introduction: Recombinant factor VIIa (rFVIIa; NovoSeven) is well recognized as an effective hemostatic agent in the management and prophylaxis of patients with hemophilia. We report here the successful use of rFVIIa in a coagulopathic burn patient. Methods: A 63-year-old man was admitted with signi...
Autores principales: | Martin, Jeremiah T., Alkhoury, Fuad, McIntosh, Bryan C., Fidler, Phillip, Schulz, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Open Science Company, LLC
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705287/ https://www.ncbi.nlm.nih.gov/pubmed/19649159 |
Ejemplares similares
-
Preclinical trauma studies of recombinant factor VIIa
por: Schreiber, Martin A, et al.
Publicado: (2005) -
Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven(®)) utilization at a large academic medical center
por: Marsh, Kassandra, et al.
Publicado: (2020) -
Use of recombinant factor VIIa in orthotopic liver transplant
por: Bhatia, Pradeep
Publicado: (2011) -
Safety of percutaneous tracheostomy in coagulopathic patients
por: Myatra, S, et al.
Publicado: (2006) -
Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)